Intelligent Bio Solutions Inc. (NASDAQ:INBS) Sees Large Drop in Short Interest

Intelligent Bio Solutions Inc. (NASDAQ:INBS) saw a large drop in short interest in November. As of November 30th, there was short interest totalling 508,200 shares, a drop of 10.0% from the November 15th total of 564,600 shares. Based on an average daily volume of 287,400 shares, the short-interest ratio is currently 1.8 days. Currently, 11.9% of the shares of the stock are short sold.

Intelligent Bio Solutions Stock Down 0.7 %

Shares of NASDAQ INBS opened at $1.47 on Tuesday. The company has a 50-day moving average of $1.55 and a 200 day moving average of $1.63. Intelligent Bio Solutions has a 12-month low of $1.00 and a 12-month high of $11.70.

Intelligent Bio Solutions (NASDAQ:INBS) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.70) EPS for the quarter, missing analysts’ consensus estimates of ($0.53) by ($0.17). Intelligent Bio Solutions had a negative return on equity of 147.50% and a negative net margin of 288.35%. The company had revenue of $872.29 million for the quarter. As a group, research analysts forecast that Intelligent Bio Solutions will post -1.25 earnings per share for the current fiscal year.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.